SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (290)3/15/1999 9:13:00 AM
From: Volsi Mimir  Read Replies (1) | Respond to of 579
 
SIBIA Neurosciences Announces Issuance of United States Patents
biz.yahoo.com
LA JOLLA, Calif., March 15 /PRNewswire/ -- SIBIA Neurosciences, Inc. (Nasdaq: SIBI - news) today announced the recent issuance by the United States Patent and Trademark Office of United States Patent No. 5,863,902 relating to the Company's novel compounds and methods for treating amyloid plaque deposition in Alzheimer's disease, and patents 5,587,958, 5,874,236 and 5,876,958 relating to drug screening directed at voltage-gated calcium channels which are implicated in chronic pain, epilepsy, stroke and migraine, diseases with significant unmet needs in treatment.